Vetter MH, Smrz SA, Copeland LJ, Cohn DE, et al. Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19. Am J Obstet Gynecol 2020 May 23. pii: S0002-9378(20)30569.
PMID: 32454030